Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

A Francisella novicida Mutant, Lacking the Soluble Lytic Transglycosylase Slt, Exhibits Defects in Both Growth and Virulence.

Bachert BA, Biryukov SS, Chua J, Rodriguez SA, Toothman RG Jr, Cote CK, Klimko CP, Hunter M, Shoe JL, Williams JA, Kuehl KA, Biot FV, Bozue JA.

Front Microbiol. 2019 Jun 14;10:1343. doi: 10.3389/fmicb.2019.01343. eCollection 2019.

2.

Correction: Two stable variants of Burkholderia pseudomallei strain MSHR5848 express broadly divergent in vitro phenotypes associated with their virulence differences.

Shea AA, Bernhards RC, Cote CK, Chase CJ, Koehler JW, Klimko CP, Ladner JT, Rozak DA, Wolcott MJ, Fetterer DP, Kern SJ, Koroleva GI, Lovett SP, Palacios GF, Toothman RG, Bozue JA, Worsham PL, Welkos SL.

PLoS One. 2019 Apr 4;14(4):e0215200. doi: 10.1371/journal.pone.0215200. eCollection 2019.

3.

Formaldehyde and Glutaraldehyde Inactivation of Bacterial Tier 1 Select Agents in Tissues.

Chua J, Bozue JA, Klimko CP, Shoe JL, Ruiz SI, Jensen CL, Tobery SA, Crumpler JM, Chabot DJ, Quirk AV, Hunter M, Harbourt DE, Friedlander AM, Cote CK.

Emerg Infect Dis. 2019 May;25(5):919-926. doi: 10.3201/eid2505.180928. Epub 2019 May 17.

4.

Disease progression in mice exposed to low-doses of aerosolized clinical isolates of Burkholderia pseudomallei.

Trevino SR, Klimko CP, Reed MC, Aponte-Cuadrado MJ, Hunter M, Shoe JL, Meyer JR, Dankmeyer JL, Biryukov SS, Quirk AV, Fritts KA, Kern SJ, Fetterer DP, Kohler LJ, Toothman RG, Bozue JA, Schellhase CW, Kreiselmeier N, Daye SP, Welkos SL, Soffler C, Worsham PL, Waag DM, Amemiya K, Cote CK.

PLoS One. 2018 Nov 30;13(11):e0208277. doi: 10.1371/journal.pone.0208277. eCollection 2018.

5.

A Standard Method To Inactivate Bacillus anthracis Spores to Sterility via Gamma Irradiation.

Cote CK, Buhr T, Bernhards CB, Bohmke MD, Calm AM, Esteban-Trexler JS, Hunter M, Katoski SE, Kennihan N, Klimko CP, Miller JA, Minter ZA, Pfarr JW, Prugh AM, Quirk AV, Rivers BA, Shea AA, Shoe JL, Sickler TM, Young AA, Fetterer DP, Welkos SL, Bozue JA, McPherson D, Fountain AW 3rd, Gibbons HS.

Appl Environ Microbiol. 2018 May 31;84(12). pii: e00106-18. doi: 10.1128/AEM.00106-18. Print 2018 Jun 15.

6.

A spontaneous mutation in kdsD, a biosynthesis gene for 3 Deoxy-D-manno-Octulosonic Acid, occurred in a ciprofloxacin resistant strain of Francisella tularensis and caused a high level of attenuation in murine models of tularemia.

Chance T, Chua J, Toothman RG, Ladner JT, Nuss JE, Raymond JL, Biot FV, Demons S, Miller L, Halasohoris S, Mou S, Koroleva G, Lovett S, Palacios G, Vietri NJ, Worsham PL, Cote CK, Kijek TM, Bozue JA.

PLoS One. 2017 Mar 22;12(3):e0174106. doi: 10.1371/journal.pone.0174106. eCollection 2017.

7.

Characterization of pathogenesis of and immune response to Burkholderia pseudomallei K96243 using both inhalational and intraperitoneal infection models in BALB/c and C57BL/6 mice.

Bearss JJ, Hunter M, Dankmeyer JL, Fritts KA, Klimko CP, Weaver CH, Shoe JL, Quirk AV, Toothman RG, Webster WM, Fetterer DP, Bozue JA, Worsham PL, Welkos SL, Amemiya K, Cote CK.

PLoS One. 2017 Feb 24;12(2):e0172627. doi: 10.1371/journal.pone.0172627. eCollection 2017.

8.

Two stable variants of Burkholderia pseudomallei strain MSHR5848 express broadly divergent in vitro phenotypes associated with their virulence differences.

Shea AA, Bernhards RC, Cote CK, Chase CJ, Koehler JW, Klimko CP, Ladner JT, Rozak DA, Wolcott MJ, Fetterer DP, Kern SJ, Koroleva GI, Lovett SP, Palacios GF, Toothman RG, Bozue JA, Worsham PL, Welkos SL.

PLoS One. 2017 Feb 10;12(2):e0171363. doi: 10.1371/journal.pone.0171363. eCollection 2017. Erratum in: PLoS One. 2019 Apr 4;14(4):e0215200.

9.

Phenotypic Characterization of a Novel Virulence-Factor Deletion Strain of Burkholderia mallei That Provides Partial Protection against Inhalational Glanders in Mice.

Bozue JA, Chaudhury S, Amemiya K, Chua J, Cote CK, Toothman RG, Dankmeyer JL, Klimko CP, Wilhelmsen CL, Raymond JW, Zavaljevski N, Reifman J, Wallqvist A.

Front Cell Infect Microbiol. 2016 Feb 26;6:21. doi: 10.3389/fcimb.2016.00021. eCollection 2016.

10.

The Bacillus anthracis Exosporium: What's the Big "Hairy" Deal?

Bozue JA, Welkos S, Cote CK.

Microbiol Spectr. 2015 Oct;3(5). doi: 10.1128/microbiolspec.TBS-0021-2015. Review.

PMID:
26542035
11.

A Unique Set of the Burkholderia Collagen-Like Proteins Provides Insight into Pathogenesis, Genome Evolution and Niche Adaptation, and Infection Detection.

Bachert BA, Choi SJ, Snyder AK, Rio RV, Durney BC, Holland LA, Amemiya K, Welkos SL, Bozue JA, Cote CK, Berisio R, Lukomski S.

PLoS One. 2015 Sep 10;10(9):e0137578. doi: 10.1371/journal.pone.0137578. eCollection 2015.

12.

Characterization of Burkholderia pseudomallei Strains Using a Murine Intraperitoneal Infection Model and In Vitro Macrophage Assays.

Welkos SL, Klimko CP, Kern SJ, Bearss JJ, Bozue JA, Bernhards RC, Trevino SR, Waag DM, Amemiya K, Worsham PL, Cote CK.

PLoS One. 2015 Apr 24;10(4):e0124667. doi: 10.1371/journal.pone.0124667. eCollection 2015.

13.

Interrogation of the Burkholderia pseudomallei genome to address differential virulence among isolates.

Challacombe JF, Stubben CJ, Klimko CP, Welkos SL, Kern SJ, Bozue JA, Worsham PL, Cote CK, Wolfe DN.

PLoS One. 2014 Dec 23;9(12):e115951. doi: 10.1371/journal.pone.0115951. eCollection 2014. Erratum in: PLoS One. 2015;10(3):e0122178.

14.

The impact of inducing germination of Bacillus anthracis and Bacillus thuringiensis spores on potential secondary decontamination strategies.

Omotade TO, Bernhards RC, Klimko CP, Matthews ME, Hill AJ, Hunter MS, Webster WM, Bozue JA, Welkos SL, Cote CK.

J Appl Microbiol. 2014 Dec;117(6):1614-33. doi: 10.1111/jam.12644. Epub 2014 Oct 19.

15.

Exposure to Bacillus anthracis capsule results in suppression of human monocyte-derived dendritic cells.

Jelacic TM, Chabot DJ, Bozue JA, Tobery SA, West MW, Moody K, Yang D, Oppenheim JJ, Friedlander AM.

Infect Immun. 2014 Aug;82(8):3405-16. doi: 10.1128/IAI.01857-14. Epub 2014 Jun 2. Erratum in: Infect Immun. 2014 Dec;82(12):5347.

16.

D-cycloserine or similar physiochemical compounds may be uniquely suited for use in Bacillus anthracis spore decontamination strategies.

Omotade TO, Heffron JD, Klimko CP, Marchand CL, Miller LL, Halasahoris SA, Bozue JA, Welkos SL, Cote CK.

J Appl Microbiol. 2013 Dec;115(6):1343-56. doi: 10.1111/jam.12322. Epub 2013 Aug 30.

17.

Phenotypic changes in spores and vegetative cells of Bacillus anthracis associated with BenK.

Heffron JD, Jenkins AL, Bozue JA, Kaatz LK, Cote CK, Welkos SL.

Microb Pathog. 2013 Apr;57:41-51. doi: 10.1016/j.micpath.2012.11.009. Epub 2012 Nov 22.

PMID:
23178382
18.

Allelic variation on murine chromosome 11 modifies host inflammatory responses and resistance to Bacillus anthracis.

Terra JK, France B, Cote CK, Jenkins A, Bozue JA, Welkos SL, Bhargava R, Ho CL, Mehrabian M, Pan C, Lusis AJ, Davis RC, LeVine SM, Bradley KA.

PLoS Pathog. 2011 Dec;7(12):e1002469. doi: 10.1371/journal.ppat.1002469. Epub 2011 Dec 29.

19.

Cutting edge: resistance to Bacillus anthracis infection mediated by a lethal toxin sensitive allele of Nalp1b/Nlrp1b.

Terra JK, Cote CK, France B, Jenkins AL, Bozue JA, Welkos SL, LeVine SM, Bradley KA.

J Immunol. 2010 Jan 1;184(1):17-20. doi: 10.4049/jimmunol.0903114. Epub 2009 Nov 30.

20.

Identification of genes involved in the expression of atypical lipooligosaccharide structures from a second class of Haemophilus ducreyi.

Post DM, Munson RS Jr, Baker B, Zhong H, Bozue JA, Gibson BW.

Infect Immun. 2007 Jan;75(1):113-21. Epub 2006 Oct 9.

21.

Construction of a rhamnose mutation in Bacillus anthracis affects adherence to macrophages but not virulence in guinea pigs.

Bozue JA, Parthasarathy N, Phillips LR, Cote CK, Fellows PF, Mendelson I, Shafferman A, Friedlander AM.

Microb Pathog. 2005 Jan;38(1):1-12. Epub 2005 Jan 6.

PMID:
15652290
22.

Haemophilus influenzae type b strain A2 has multiple sialyltransferases involved in lipooligosaccharide sialylation.

Jones PA, Samuels NM, Phillips NJ, Munson RS Jr, Bozue JA, Arseneau JA, Nichols WA, Zaleski A, Gibson BW, Apicella MA.

J Biol Chem. 2002 Apr 26;277(17):14598-611. Epub 2002 Feb 12.

23.

Expression of sialylated or paragloboside-like lipooligosaccharides are not required for pustule formation by Haemophilus ducreyi in human volunteers.

Young RS, Fortney K, Haley JC, Hood AF, Campagnari AA, Wang J, Bozue JA, Munson RS Jr, Spinola SM.

Infect Immun. 1999 Dec;67(12):6335-40.

25.

Facile construction of mutations in Haemophilus ducreyi using lacZ as a counter-selectable marker.

Bozue JA, Tarantino L, Munson RS Jr.

FEMS Microbiol Lett. 1998 Jul 15;164(2):269-73.

Supplemental Content

Loading ...
Support Center